Influence of specific prevention on the infectious activity of the virus tick-borne encephalitis (review of own research)
https://doi.org/10.22625/2072-6732-2022-14-1-43-52
Abstract
The results of our own long-term research on the effectiveness of specific prevention of viral infectious diseases using the example of tick-borne encephalitis are presented in the article. The peculiarities of the formation of the immune response during vaccination against tick-borne encephalitis are shown on the model of the vaccine preparation «Encepur® adult» (Germany). The terms of revaccination were substantiated, taking into account the ELISA parameters of the immunity intensity to the tick-borne encephalitis virus, equal to not less than 1: 400. The experiment shows the mechanisms of passive immunization of persons infected with the tick-borne encephalitis virus, based on the protective effect of specific antibodies. The established high level of immune protection during complex vaccination with drugs against tick-borne encephalitis from different manufacturers helps to understand its effectiveness in relation to vaccination against other infections.
About the Author
G. N. Leonova
Science Research Institute of Epidemiology and Microbiology named after G.P. Somov
Russian Federation
Russian Federation
Vladivostok
References
1. Petrova A.G., Bayanova T.A., Vanyarkina A.S., Rychkova L.V. Views of the physicians of different specialities on the vaccination: concerns and expectations. Zhurnal Infektologii 2020; 12(2):104-112. DOI: 10.22625/2072-6732-2020-12-2-104-112 (in Russian)
2. Heinze D.M., Gould E.A., Forrester N.L. Revisiting the clinal concept of evolution and dispersal for the tick-borne flaviviruses by using phylogenetic and biogeographic analyses. // J Virol. 2012; V.86: 8663-8671. doi: 10.1128/JVI.01013-12
3. Lindenbach, B.D. Flaviviridae: The viruses and their replication. In: Knippe DM, Howley PM. Editors. Fundamental Virology // Philadelphia: Lippincott Williams &Wilkins. 2001: 589-641.
4. Heinz, F.X. C.W. Mandl. The molecular biology of tickborne encephalitis virus. //APMIS 1993; V.101: 735-745.
5. Pletnev A.G., Yamshchikov V.F. N-terminal amino acid sequences of tick-borne encephalitis virus structural proteins. Bioorganicheskaya himiya. 1985;11(12): 1681-1684 (in Russian).
6. Pletnev A.G., Yamshchikov V.F., Blinov V.M. Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus // Virology. 1990; 174(1): 250-263.
7. Roehrig, J.T. Antigenic structure of flavivirus proteins / J.T. Roehrig. // Adv. Virus. Res. 2003; Vol.59: 141-175.
8. Ecker M., Allison S.L., Meixner T., Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europa and Asia. J. Gen. Virol., 1999; 80: 179–185. doi: 10.1099/0022-1317-80-1-179
9. King, A.M.Q., Adams, M.J., Carstens, E.B. and Lefkowitz, E.J. Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. Ed: San Diego: Elsevier. 2012; 1003-1020.
10. Belikov S.I. et al. Analysis of genome-wide sequences of the Far Eastern subtype strains of tick-borne encephalitis virus with variable neurovirulence for humans // Byull. Sib. Otdel. RAMN. 2007; №4: 22-28 (in Russian).
11. Belikov SI, Kondratov IG, Potapova UV, Leonova GN The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties // PLoS One. 9(4):e94946. 2014. doi:10.1371/journal.pone.0094946.
12. Leonova G.N., Belikov S.I., Kondratov I.G. Characteristics of far eastern strains of tick-borne encephalitis virus // Arch Virol 2017. DOI 10.1007/s00705-017-3309-1.
13. Leonova G.N., Belikov S.I. Phylogenetic analysis and distribution of the tick-borne encephalitis virus of the Far Eastern subtype in Asia. Vopr. Virusologii. 2019; 64(5) DOI: https://doi.org/10.36233/0507-4088-2019-64-5-250-256 (in Russian)
14. Vorobieva M.S. at al. The history of creation and quality assessment of modern tick-borne encephalitis vaccines of domestic and foreign production // Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya. 2013; №3: 40–44 (in Russian).
15. Leonova G.N. Tick-borne encephalitis: topical aspects. Moscow: I.V.Balabanov, 2009. – 168. (in Russian).
16. Vaccines and vaccinations. National leadership. Short edition / ed. V.V. Zvereva, R.M. Khaitova. – M.: GEOTARMedia. 2014: 640 (in Russian).
17. Afonina O.S., Terehina L.L., Barhaleva O.A., Ladyzhenskaja I.P., Sarkisjan K.A., Vorob’eva M.S. Experimental study of cross-immune response to TBE virus antigens different genotypes strains in myshe Balbi/c immunized with different variants of tick-borne encephalitis vaccine. Epidemiologija i vakcinoprofilaktika. 2014; 5 (78): 88 – 96 (in Russian).
18. Medunitsin N.V. Side effects of vaccines // Biopreparaty. 2001; №3:10-12 (in Russian).
19. Leonova G.N., et al. Reactogenicity of the vaccine against tick-borne encephalitis “Encepur®Adult” and the immune response to its administration // Med. immunol. 2005; 7(4): 391-396 (in Russian).
20. Kenneth Lundstrom The Potential of RNA Vaccines for Infectious Diseases and COVID-19. Vaccine Research 2020; 7(1): 25-37. DOI: 10.29252/vacres.7.1.25
21. Kneitz R.H., Schubert J., Tollmann F., Zens W., Hedman K., Wissbrich B. A new method for determination of varicellazoster virus immunoglobulin G avidity in serum and cerebrospinal fluid // BMC Infections Diseases. 2004; №4: 33.
22. Raspopin V.V. et al. Avidity index of specific IgG in the diagnosis of diseases caused by West Nile viruses and tickborne encephalitis // Klin. lab. diagnostika. 2007; №4: 29-32 (in Russian).
23. Simmons V., Porter K.R., Hayes C.G., Vaughn D.M., Putnak R. Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques // J. Virology. 2006; № 10: 9577-85.
24. Hangartner L., Zinkernagel R.M., Hengartner H. Antiviral antibody responses: The two extremes of a wide spectrum // Nature Reviews in Immunology. 2006; № 6: 231-243.
25. Vauloup-Fellous C., Grangeot-Keros Humoral Immune Response after Primary Rubella Virus Infection and after Vaccination // Clin. Vaccine Immunol. 2007; №5: 644-647.
26. Briko N.I. Criteria for evaluating the effectiveness of vaccination // Vakcinaciya. 2000; 5(11): 6-7. (in Russian).
27. Leonova G.N., Pavlenko E.V., Maystrovskaya O.S., Chausov E.V. Protective antibody titer for patients vaccinated against tick-borne encephalitis. Procedia in Vaccinology. 2011; vol. 4: 84-91. doi: http://dx.doi.org/10.1016/j.provac.2011.07.012
28. Morozova O.V., Bakhvalova V.N., Potapova O.F., et al. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus // Vaccine. 2014; Vol. 32, N 25: 3101-3106. doi: 10.1016/j.vaccine.2014.02.046.
29. Kunz C.H., Heinz F., Hofmann H. Immunogenicity and Reactogenicity of a Highly Purified Vaccine against Tick-borne Encephalitis. J. Med. Virol., 1980; no. 6:103-109. https://doi.org/10.1002/jmv.1890060202
30. Leonova G.N., Pavlenko E.V. Characterization of neutralizing antibodies to Far Eastern of tick- borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine, 2009; 27(21): 2899-2904. https://doi: 10.1016/j.vaccine.2009.02.069
31. Pogodina V.V. Actual problems of tick-borne encephalitis at the turn of XX-XXI centuries. Medicinskaya virusologiya, 2015, vol. 29, no. 2, pp. 24-32 (in Russian).
32. Leonova G.N., Lubova V.A., Kalinin A.V. The effect of the level of specific antibodies on elimination of different tickborne encephalitis virus strains. Ehpidemiologiya i vakcinoprofilaktika, 2017; 2(93): 50-56. doi: https://doi.org/10.31631/2073-3046-2017-16-2-50-54 (in Russian).
33. Leonova G.N. et al. Comprehensive assessment of the effect of specific antibodies on the infectious activity of the tick-borne encephalitis virus. Infekciya i immunitet. 2019; 9(3–4):559–567. DOI: http://dx.doi.org/10.15789/2220-7619-2019-3-4-559-567 (in Russian)
34. Sanitary rules 3.1.3.2352-08 «Prevention of tick-borne encephalitis»: http://docs.cntd.ru/document/902094567 (in Russian)
35. Pogodina V.V., Levina L.S., Skrynnik S.M., Travina N.S., Karan L.S., Kolyasnikova N.M., Kamysheva V.Ya., Gerasimov S.G., Malenko G.V., Perminov L.V., Popov M.A., Bochkova N.G. Tick-borne encephalitis with fulminant course and lethal outcome in patients after plural vaccination. Voprosy virusologii=Problems of virology, 2013, no. 2, pp. 33-37 (in Russian).
36. Pen’evskaya N.A., Rudakov N.V. Efficiency of the use of immunoglobulin preparations for post-exposure prophylaxis of tick-borne encephalitis in Russia (a review of half a century of experience) // Medicinskaya parazitologiya i parazitarnye bolezni. 2010; №1: 53 59 (in Russian).
37. Pen’evskaya N.A., et al. Meta-analysis of the effectiveness of the use of immunoglobulin preparations for post-exposure prophylaxis of tick-borne encephalitis in Russia. Medicinskaya parazitologiya i parazitarnye bolezni. 2010; №3: 58-63 (in Russian).
38. Leonova G.N., Pavlenko E.V. Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine, 2009; 27(21): 2899–2904. doi: 10.1016/j.vaccine.2009.02.069
39. Heinz F.X., Holzmann H., Essl A., Kundt M. Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria. Voprosy virusologii=Problems of virology. 2008; 53(2):19–27 (in Russian).
40. Heinz F.X., Kunz C. Tick-borne encephalitis and the impact of vaccination. Arch. Virol., 2004; vol. 18: 201-205.
41. Esyunina M.S., Romanenko V.V., Kilyachina A.S. Duration of maintenance of post-vaccination immunity to tick-borne encephalitis virus after revaccinations // Medicinskaya virusologiya. 2015; 29(2): 132 (in Russian).
42. Shapoval A.N. Tick-borne encephalitis. Moskva. Medicina; 1980 (in Russian).
43. Vereta L.A., Zakharycheva T.A., Aleksandrov V.I. The relationship of the therapeutic effectiveness of immunoglobulin against tick-borne encephalitis with the specific activity of the drug and the timing of its administration. Nevrologiya i psihiatriya. 1994; №2:68–70 (in Russian).
44. Vorobieva M.S., et al. Current state of incidence and specific seroprevention of tick-borne encephalitis in Russia. Biopreparaty. 2005; №3:20–8 (in Russian).
45. Olefir Yu.V., Merkulov V.A., Vorobyova M.S., Rukavishnikov A.V., Bondarev V.P., Shevtsov V.A. Domestic preparation of human immunoglobulin for emergency prevention and treatment of tick-borne encephalitis // Immunologiya. 2015; № 6:353-357 (in Russian).
46. Ruzek D., Županc T.A., Borde J., et al. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines // Antiviral Research. 2019; Vol. 164: 23–51. https://doi.org/10.1016/j.antiviral.2019.01.014.
47. Kreil T.R., Eibl M.M. Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model // J. Virol. 1997;71(4): 2921-2927
48. Elsterova J., Palus M., Sirmarova J., et al. Tick-borne encephalitis virus neutralization by high dose intravenous immunoglobulin // Ticks and Tick-borne Diseases. 2017; 8(2): 253-258. https://doi.org/10.1016/j.ttbdis.2016.11.007.
49. Elgundi Z., Reslan M., Cruz E., et al.The state-of-play and future of antibody therapeutics // Advanced Drug Delivery Reviews. 2017; 122(1): 2-19. https://doi.org/10.1016/j.addr.2016.11.004.
50. Secher T., Guilleminault L., Reckampe K., et al. Therapeutic antibodies: A new era in the treatment of respiratory diseases? // Pharmacology & Therapeutics. 2018; Vol. 189:149–172. https://doi.org/10.1016/j.pharmthera.2018.05.003.
51. Griffin D., Levine B., Tyor W., et al. The role of antibody in recovery from alphavirus encephalitis // Immunol. Rev. 1997; Vol. 159: 155-161.
52. Kreil T.R., Maier E., Fraiss S., et al. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein // J Virol. 1998; 72 (4): 3076-3081.
53. Pierson Th.C., Diamond M.S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection // Exp. Rev. Mol. Med. 2008; Vol. 10: e12. doi: 10.1017/S1462399408000665.
54. Pelegrin M., Naranjo-Gomez M., Piechaczyk M. Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents? // Trends in Microbiology. 2015; 23(10): 653-665. http://dx.doi.org/10.1016/j.tim.2015.07.005.
55. Leonova G. N. Mechanisms of Protective Actions of Specific Antibodies against the Tick-Borne Encephalitis Virus Bulletin of Experimental Biology and Medicine. 2020; vol. 169: 657–660. https://doi.org/10.1007/s10517-020-04948-w (in Russian)
56. Kozlova I.V., Zlobin V.I., Vorob’eva M.S., Verkhozina M.M. Express diagnostics and emergency prevention of ixodic tick-borne infections. М.; 2009. – 216. (in Russian).
57. Penievskaya N.A. Evaluation of the effectiveness of etiotropic prevention of infections transmitted by ixodid ticks: problems of theory and practice. Omsk; 2010. – 232. (in Russian).
58. Briko N.I. et al. Zhurnal infektologii. 2018;10(2):5-16. doi: 10.22625/2072-6732-2018-10-2-5-16 (in Russian).
Review
For citations:
Leonova G.N. Influence of specific prevention on the infectious activity of the virus tick-borne encephalitis (review of own research). Journal Infectology. 2022;14(1):43-52. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-1-43-52
Views:
472
.png)
.png)
Email this article 